Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Social media

Amy Taylor

BSc (Hons) MSc (Res)

Operational Lead NDS SITU

  • Operational Lead NDS SITU
  • FUTURE-GB Trial Manager

I am an Operational Lead for NDS SITU, overseeing a portfolio of surgical clinical trials that cover areas as diverse as melanoma and brain tumours to chronic rhinosinusitis and upper GI surgery. I help in the initial application and assessment stages, and then oversee the set up and implementtation of the trial post-award. I provide ongoing management and guidance to trials at all stages, assisting the trial managers and clinical teams as needed.

I am also Clinical Trial Manger for the FUTURE-GB trial (Functional and Ultrasound Guided Resection of Glioblastoma), in SITU (NDS). FUTURE-GB is a 2-Stage trial. The first stage is an IDEAL Stage 2b cohort study. Stage 2 is a prospective, multicentre randomised controlled trial, to investigate if additional imaging use before and during brain tumour surgery can improve outcomes for patients. 

Prior to this, I worked in SITU (NDORMS) as a Clinical Trial Manager for NINJA - a large paediatric plastic surgery trial, and also on the feasibility study, SPINOUT-F. Previously I have been a research coordinator on a large vascular study in NDS, and before that, worked in behavioural neuroscience research for 13 years across various University departments. I gained my MSc (Res) from the University of Oxford looking at the role of excitatory amino acid receptor subtypes in hippocampal-dependent learning and memory.